3van der Poel C,Noel L,Barbara J,et al.ISBA working party on transmissible diseases:report on the workshop infections disease testing and quality control[J].Vox Sang,1996,70(1):53
2Goncales FL, Stucchi RS, Papaiordannou PM, et al. Elevated alanine aminotransferase (ALT) in blood donors: an assessment of the main associated conditions and its relationship to the development of hepatitis C. Rev Inst Med Trop Sao Paulo, 1998,40(4) :219
3Ramesh V,saraswat S,Choudhury N,et al. Relationship of serum alanine aminotransferase (ALT) to body mass index (BMI)in blood donors: the need to correct ALT for BMI in blood donor screening. Transfusion Med, 1995,5 (4) : 273
4Trouern J J, Wolf JS, Xu YL, et al. Seroprevalence of known and putative hepatitis markers in United States blood donors with ALT levels at least 120 IU per L. Transfusion,2001,41(6):751
5Bergmeyer HU, Scheibe P, Wahlefeld AW. Optimization of methods for aspartate aminotransferase and alanine aminotransferase. Clin Chem, 1978,24 (1): 58
6Lozano M, Cid J, Bedini JL, et al. Study of serum alanine aminotransferase levels in blood donors in Spain. Haematologica,1998,83(3) :237
7Spuriing CL. Controversies in transfusion medicine ALT screening of blood donors: Con. Transfusion, 1990,30 (4): 368
8van der Poel C, Noel L, Barbara J, et al. ISBT working party on transmissible diseases: report on the workshop 1'infectious- disease testing and quality control. Vox Sang, 1996,70( 1 ): 53
9Tsai JF, Jeng JE, Ho MS,et al. Serum alanine aminotransferase level in relation to hepatitis B and C virus infections amongblood donors. Liver, 1997,17 (1) : 24
10Cable R, Badon S, Pray C, et al. Limited utility of alanine aminotransferase screening of hepatitis C antibody-screened blood donors. Transfusion, 1997,37 (2): 206
